Opioid Use Disorder (OUD) Market Size, Share, Growth, Industry Trends And Global Forecast 2023-2032 | Pfizer Inc., Novartis AG, AstraZeneca plc., Viatris Inc., Teva Pharmaceutical Industries Ltd.

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Opioid Use Disorder (OUD) Global Market Report 2023 identifies growing number of opioid addiction cases as the major driver for the opioid use disorder (OUD) market's growth in the forecast period. The growing number of opioid addiction cases is expected to propel the growth of the opioid use disorder (OUD) market going forward. Opioid addiction refers to a medical condition characterized by compulsive and chronic opioid use that has harmful effects on the body. Opioids can produce a sense of euphoria and pain relief, whose continued usage can lead to the development of tolerance, where higher doses are needed to achieve the same effect, which may lead to opioid use disorder.
The global opioid use disorder (OUD) market is expected to grow from $3.17 billion in 2022 to $3.53 billion in 2023 at a compound annual growth rate (CAGR) of 11.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The opioid use disorder (OUD) market is expected to reach $5.37 billion in 2027 at a CAGR of 11%.

Download Free Sample Of Opioid Use Disorder (OUD) Market Report -
https://www.thebusinessresearchcompany.com/sample_request?id=12586&type=smp

Major competitors in the opioid use disorder (OUD) market are Pfizer Inc., Novartis AG, AstraZeneca plc., Viatris Inc., Teva Pharmaceutical Industries Ltd.,

A key trend in the opioid use disorder (OUD) market includes product innovation. Major companies operating in the opioid use disorder (OUD) market are developing innovative products to sustain their position in the market. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, approved Brixadi (buprenorphine) extended-release injection to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two dosage forms a weekly injection for patients who began treatment with a single dose of a transmucosal buprenorphine product or who are currently taking the medication and a monthly version for those who are already receiving the medication.

Read More On The Global Opioid Use Disorder (OUD) Market Report Here:
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

The opioid use disorder (OUD) market is segmented -
•By Drug Type: Buprenorphine, Naltrexone, Methadone
•By Route of Administration: Oral, Parenteral
•By Age Group: 19 To 40, 41 To 60, 61 And Over
•By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
•By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the opioid use disorder (OUD) market.

The Business Research Company's "Global Opioid Use Disorder (OUD) Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Opioid Use Disorder (OUD) Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

The Table Of Content For The Opioid Use Disorder (OUD) Market Include:
1. Executive Summary
2. Opioid Use Disorder (OUD) Market Characteristics
3. Opioid Use Disorder (OUD) Market Trends And Strategies
4. Opioid Use Disorder (OUD) Market - Macro Economic Scenario
5. Global Opioid Use Disorder (OUD) Market Size and Growth
……
32. Global Opioid Use Disorder (OUD) Market Competitive Benchmarking
33. Global Opioid Use Disorder (OUD) Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Opioid Use Disorder (OUD) Market
35. Opioid Use Disorder (OUD) Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.